Guru Ownership Trend
Guru Analysis for Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $571,747.4.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $840,495.34 net outflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 8.6%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 64.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Context Therapeutics Inc. (CNTX)
Major holders include Renaissance Technologies (RenTech) ($479,457), Steven Cohen ($149,945). According to the latest reported data, 2 tracked investment managers collectively hold approximately 240,230 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $840,495.34, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CNTX. The total reported sell value was $852,363.92.
Yes, 0 managers opened new positions in CNTX, and 1 increased their existing holdings. The total reported buy value was $11,868.58.